Skip to main content
Have a personal or library account? Click to login
How well are clinical gross tumor volume DVHs approximated by an analytical function? Cover

How well are clinical gross tumor volume DVHs approximated by an analytical function?

Open Access
|Jun 2009

References

  1. Ebert MA. Viability of the EUD and TCP concepts as reliable dose indicators.2000; 45: 441-57.
  2. Stavrev P, Schinkel C, Stavreva N, Warkentin B, Fallone B. Population TCP estimators in case of heterogeneous irradiation.2007; 84: S279-S80.
  3. Nahum AE, Sanchez-Nieto B. Tumour control probability modelling: basic principles and applications in treatment planning.2001; XVII(Suppl 2): 13-23.
  4. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.2002; 52: 224-35.
  5. De Gersem WR, Derycke S, Colle CO, De Wagter C, De Neve WJ. Inhomogeneous target-dose distributions: a dimension more for optimization?1999; 44: 461-8.
  6. De Gersem WR, Derycke S, De Wagter C, De Neve WC. Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio.2000; 47: 255-60.
  7. Mohan R, Mageras GS, Baldwin B, Brewster LJ, Kutcher GJ, Leibel S, et al. Clinically relevant optimization of 3-D conformal treatments.1992; 19: 933-44.
  8. Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant WH 3rd, Lu HH, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.2001; 49: 705-12.
  9. Reinstein LE, Wang XH, Burman CM, Chen Z, Mohan R, Kutcher G, et al. A feasibility study of automated inverse treatment planning for cancer of the prostate.1998; 40: 207-14.
  10. Stanescu T, Hans-Sonke J, Stavrev P, Fallone B. 3T MR-based treatment planning for radiotherapy of brain lesions.2006; 40: 125-32.
  11. Bos LJ, Damen EMF, DeBoer RW, Mijnheer BJ, McShan DL, Fraass BA, et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation.2002; 52: 254-65.
  12. Nederveen AJ, VanderHeide UA, Hofman P, Welleweerd H, Lagendijk JJW. Partial boosting of prostate tumours.2001; 61: 117-26.
  13. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensitymodulated techniques.2001; 60: 157-63.
  14. Ólafsson A, Jeraj R, Wright SJ. Optimization of intensity-modulated radiation therapy with biological objectives.2005; 50: 5357-79.
  15. Stavrev P, Stavreva N, Schinkel C, Fallone B. An objective function for TCP/NTCP curve fitting.2007; 34: 2417-8.
DOI: https://doi.org/10.2478/v10019-009-0016-x | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 132 - 135
Published on: Jun 8, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Pavel Stavrev, Colleen Schinkel, Nadia Stavreva, B. Falloned, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.